http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-210750935-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61c88792ba37ba7ccc97e25128cb7d6c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M36-12 |
| filingDate | 2018-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_898b8e5e5eab7849be489cc6a0a9cf58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3455047038301a0848c224a8d9eb72e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adf4f51799d66247663abc9447f927b5 |
| publicationDate | 2020-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-210750935-U |
| titleOfInvention | Portal vein cancer embolus and bile duct cancer embolus treatment assembly |
| abstract | The utility model discloses a portal vein cancer embolus and bile duct cancer embolus treatment component, including pjncture needle sheath, puncture needle core and particle tube, the particle tube comprises a left solid core section and a transparent right cavity section of 13-16 cm in length, the right cavity section is provided with scale marks, the reading corresponding to the scale marks increases from left to right in turn, the right cavity section is filled with single-row iodine-125 radioactive particles, the mouth of the right cavity section is sealed and filled with gel; the needle point of the puncture needle core is of a triangular bevel needle structure. The utility model has the advantages of simple structure, can control the dosage of radioactive particles according to the length of the portal cancer embolus, accurately control the dosage of the particles, reduce the implantation times of the particles, and can take out the residual particles from the body through the particle tube, completely avoid the particles remaining, reduce the probability of portal thrombosis and the migration of the radioactive particles, and improve the safety; the particle tube is fixed on the skin of a patient through the fixing buckle and the adhesive sheet, so that the stability of the particle tube is ensured, and the pain of the patient is reduced. |
| priorityDate | 2018-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24841 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583629 |
Total number of triples: 16.